![Alon Bloomenfeld](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alon Bloomenfeld
Chief Executive Officer at Raziel Therapeutics RT Ltd.
Alon Bloomenfeld active positions
Companies | Position | Start | End |
---|---|---|---|
Raziel Therapeutics RT Ltd.
![]() Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | Director/Board Member | 2012-08-07 | - |
Chief Executive Officer | 2012-08-07 | - |
Career history of Alon Bloomenfeld
Former positions of Alon Bloomenfeld
Companies | Position | Start | End |
---|---|---|---|
Eqlibra Medical Systems Ltd.
![]() Eqlibra Medical Systems Ltd. Medical SpecialtiesHealth Technology Eqlibra Medical Systems Ltd. develops miniature intravascular flow augmentation devices. It offers tiny retrievable pump, intended to improve blood flow in the coronary arteries after an angioplasty catheterization. Its customers include medical institutions and hospitals. The company was founded on September 01, 2007 and is headquartered in Kiryat Shmona, Israel. | Chairman | 2010-05-31 | - |
ELECTREON WIRELESS LTD | Director/Board Member | 2010-01-12 | - |
Meytav Technological Enterprises Innovation Center Ltd.
![]() Meytav Technological Enterprises Innovation Center Ltd. Investment ManagersFinance Meytav Technological Enterprises Innovation Center Ltd is an Independent Venture Capital firm founded in 1991. The firm is headquartered in Kiryat Shmona. | Investment Committee Member | 2010-02-28 | - |
Orbix Medical Ltd.
![]() Orbix Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Orbix Medical Ltd. manufactures and distributes medical equipment. It offers Orbishape and Orbisymm. The company was founded by Eyal Gur in 2004 and is headquartered in Tel Aviv, Israel. | Director/Board Member | 2010-01-12 | - |
Statistics
International
Israel | 6 |
Operational
Director/Board Member | 3 |
Investment Committee Member | 1 |
Chairman | 1 |
Sectoral
Health Technology | 3 |
Electronic Technology | 2 |
Producer Manufacturing | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ELECTREON WIRELESS LTD | Producer Manufacturing |
Private companies | 4 |
---|---|
Orbix Medical Ltd.
![]() Orbix Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Orbix Medical Ltd. manufactures and distributes medical equipment. It offers Orbishape and Orbisymm. The company was founded by Eyal Gur in 2004 and is headquartered in Tel Aviv, Israel. | Electronic Technology |
Meytav Technological Enterprises Innovation Center Ltd.
![]() Meytav Technological Enterprises Innovation Center Ltd. Investment ManagersFinance Meytav Technological Enterprises Innovation Center Ltd is an Independent Venture Capital firm founded in 1991. The firm is headquartered in Kiryat Shmona. | Finance |
Eqlibra Medical Systems Ltd.
![]() Eqlibra Medical Systems Ltd. Medical SpecialtiesHealth Technology Eqlibra Medical Systems Ltd. develops miniature intravascular flow augmentation devices. It offers tiny retrievable pump, intended to improve blood flow in the coronary arteries after an angioplasty catheterization. Its customers include medical institutions and hospitals. The company was founded on September 01, 2007 and is headquartered in Kiryat Shmona, Israel. | Health Technology |
Raziel Therapeutics RT Ltd.
![]() Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | Health Technology |
- Stock Market
- Insiders
- Alon Bloomenfeld
- Experience